What type of changes does a Real Time PMA Supplement address?

• A. Significant modifications to a device
• B. Minor changes to design, software, or labeling
• C. Changes in manufacturing processes
• D. New clinical trial requirements

Answer: (B)

The Real Time PMA Supplement primarily addresses minor changes to design, software, or labeling of a medical device. This is important because such modifications can be implemented more rapidly without the need for a complete re-evaluation of the device's premarket approval. These types of changes typically do not significantly affect the device's safety or efficacy profile as originally established in the PMA application.

By utilizing a Real Time PMA Supplement, manufacturers can provide updated information or slight adjustments efficiently, allowing for continuous improvement of their devices while ensuring that regulatory oversight remains in place for alterations that may impact patient safety or performance. This mechanism supports innovation and responsiveness in the medical device landscape, ensuring that any incremental changes can be swiftly communicated and assessed by the regulatory authorities.